VALUES OF CYSTATIN C IN EARLY DIAGNOSIS OF RENAL DISEASE IN PATIENTS WITH TYP 2 DIABETES IN THAINGUYEN NATIONAL HOSPITAL

Bùi Thị Thu Hương, Nguyễn Thu Giang

Main Article Content

Abstract

Diabetic kidney disease (diabetes mellitus) is a small vascular complication that occurs early, with a high rate, is the cause of end-stage renal failure requiring periodic dialysis, early detection of the decrease in filtration Glomerular glomeruli for diabetic patients is extremely necessary. Objective: Determine the value of plasma cystatin C in early detection of kidney damage in type 2 diabetes patients. Subjects and research methods: Cross-sectional description of 89 type 2 diabetic patients on external treatment residing at the Department of Medical Examination of ThaiNguyen National Hospital. Results: There is a close correlation between the concentration of cystatinC and creatinin plasma, between eGFRcys and eGFRcre in type 2 diabetes; There is a strong inverse correlation between the concentration of cystatin C and MLCTcre in patients with type 2 diabetes; Estimating GFR by cystatin C increased by 25% (13/89) patients with renal impairment (eGFR<60 ml/p). Analyze the ROC curve with critical value of GFR 60 ml / min. The AUC of cystatin C of 0.812 is greater than that of creatinine AUC of 0.711. The difference was statistically significant (p <0.05); Conclusions: Plasma cystatin C may reflect an early decrease in glomerular filtration rate in type 2 diabetic patients.

Article Details

References

1. Trần Quốc Toản (2015), Nghiên cứu nồng độ cystatin c huyết tương, nước tiểu ở bệnh nhân đái tháo đường týp 2 có tổn thương thận, Luận án Tiến sỹ Học viện 103.
2. Yoshiji Ogawaa , Takashi Gotob,, Naoki Tamasawaa et al (2015), Serum cystatin C in diabetic patients, Diabetes reseach and clinical practice, Volume 79, Issue 2, Pages 357–361.
3. Alaaeldin M. Bashier, 1 Ayman Aly Seddik Fadlallah, 2,3 Nada Alhashemi,4 Puja Murli Thadani,1 Elamin Abdelgadir,1 and Fauzia Rashid1 (2015), Cystatin C and Its Role in Patients with Type 1 and Type 2 Diabetes Mellitus, Advances in Endocrinology, Volume 2015, 8 pages.
4. David M. Maahs, MD, PHD, 1,2 Nicole Prentice, BS,1 Kim McFann, PHD,1 Janet K. Snell-Bergeon, PHD, 1Diana Jalal, MD,2 Franziska K. Bishop, MS,1 Brittany Aragon, BS,1 and R. Paul Wadwa, MD (2011), Age and Sex Influence Cystatin C in Adolescents With and Without Type 1 Diabetes, Diabetes Care. 2011 Nov; 34(11): 2360–2362.
5. Dsa J, Shetty S, Bhandary RR, Rao AV. Association Between Serum Cystatin C and Creatinine in Chronic Kidney Disease Subjects Attending a Tertiary Health Care Centre. J Clin Diagn Res 2017 Apr; 11(4): BC09-BC12.
6. Rigalleau V. et al (2008), "Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate diabetes", Diabetes and Metabolism. 34, tr. 482 - 489.
7. Yang YS, Peng CH và Lin CK et al (2007), "Use of Serum Cystatin C to Detect Early Decline of Glomerular Filtration Rate in Type 2 Diabetes", The journal of internal medicine. 46, tr. 801 - 806.